Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

VERA holding history

Vera Therapeutics, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VERA overviewAll 13F holders of VERAFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q2 2021
Holdings of VERA by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−429,761−100.0%Sold outHolders
Q1 2026429,761$17.3M<0.1%−347,727−44.7%ReducedHolders
Q4 2025777,488$39.4M<0.1%−837,850−51.9%ReducedHolders
Q3 20251,615,338$46.9M<0.1%+1,052,472+187.0%AddedHolders
Q2 2025562,866$13.3M<0.1%+351,071+165.8%AddedHolders
Q1 2025211,795$5.09M<0.1%+156,989+286.4%AddedHolders
Q4 202454,806$2.32M<0.1%+51,736+1,685.2%AddedHolders
Q3 20243,070$135.7K<0.1%−1,581−34.0%ReducedHolders
Q2 20244,651$168.3K<0.1%−22,311−82.7%ReducedHolders
Q1 202426,962$1.16M<0.1%−12,685−32.0%ReducedHolders
Q4 202339,647$609.8K<0.1%−4,647−10.5%ReducedHolders
Q3 202344,294$607.3K<0.1%+44,294NewHolders
Q2 20230$00.0%−775,792−100.0%Sold outHolders
Q1 2023775,792$6.02M<0.1%−1,215,681−61.0%ReducedHolders
Q4 20221,991,473$38.5M<0.1%00.0%UnchangedHolders
Q3 20221,991,473$42.4M0.1%−131,378−6.2%ReducedHolders
Q2 20222,122,851$28.9M<0.1%+33,331+1.6%AddedHolders
Q1 20222,089,520$49.1M0.1%+356,338+20.6%AddedHolders
Q4 20211,733,182$46.3M<0.1%+4,834+0.3%AddedHolders
Q3 20211,728,348$29.1M<0.1%−10,345−0.6%ReducedHolders
Q2 20211,738,693$22.2M<0.1%+1,738,693NewHolders